Dentsply International Inc. (XRAY) Stock Price Down 2.5%
Dentsply International Inc. (NASDAQ:XRAY) shares were down 2.5% during mid-day trading on Thursday . The stock traded as low as $63.42 and last traded at $63.53, with a volume of 1,234,649 shares. The stock had previously closed at $65.14.
Several research analysts have recently issued reports on XRAY shares. Zacks Investment Research downgraded shares of Dentsply International from a “hold” rating to a “sell” rating in a report on Monday, April 11th. Morgan Stanley reiterated a “hold” rating and set a $65.00 price target on shares of Dentsply International in a report on Monday, May 9th. Barrington Research reiterated an “outperform” rating and set a $68.00 price target (up from $62.00) on shares of Dentsply International in a report on Friday, May 13th. Credit Suisse Group AG reiterated a “buy” rating on shares of Dentsply International in a report on Thursday, May 26th. Finally, Piper Jaffray Cos. started coverage on shares of Dentsply International in a report on Monday, June 13th. They set an “overweight” rating and a $70.00 price target for the company. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and eight have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $66.50.
The firm has a 50 day moving average price of $62.91 and a 200 day moving average price of $60.98. The firm has a market capitalization of $14.92 billion and a PE ratio of 30.96.
Dentsply International (NASDAQ:XRAY) last announced its quarterly earnings results on Friday, May 6th. The company reported $0.69 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.63 by $0.06. The firm earned $772.60 million during the quarter, compared to the consensus estimate of $741.80 million. The firm’s revenue for the quarter was up 17.7% on a year-over-year basis. During the same period in the previous year, the business earned $0.59 earnings per share. Analysts predict that Dentsply International Inc. will post $2.75 earnings per share for the current year.
In other news, VP Rainer Berthan sold 6,464 shares of Dentsply International stock in a transaction on Thursday, June 2nd. The shares were sold at an average price of $62.56, for a total transaction of $404,387.84. Following the completion of the sale, the vice president now directly owns 39,341 shares of the company’s stock, valued at approximately $2,461,172.96. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Harry M. Jansen Kraemer, Jr. sold 27,213 shares of Dentsply International stock in a transaction on Monday, May 16th. The stock was sold at an average price of $62.17, for a total transaction of $1,691,832.21. Following the sale, the director now directly owns 58,262 shares of the company’s stock, valued at $3,622,148.54. The disclosure for this sale can be found here.
Several hedge funds recently bought and sold shares of XRAY. Advisors Asset Management Inc. increased its stake in Dentsply International by 4.2% in the fourth quarter. Advisors Asset Management Inc. now owns 24,738 shares of the company’s stock worth $1,505,000 after buying an additional 992 shares in the last quarter. GAM Holding AG increased its stake in Dentsply International by 15.0% in the fourth quarter. GAM Holding AG now owns 26,643 shares of the company’s stock worth $1,621,000 after buying an additional 3,482 shares in the last quarter. Aberdeen Asset Management PLC UK increased its stake in Dentsply International by 18.2% in the fourth quarter. Aberdeen Asset Management PLC UK now owns 25,917 shares of the company’s stock worth $1,519,000 after buying an additional 3,982 shares in the last quarter. Bank of Montreal Can increased its stake in Dentsply International by 20.8% in the fourth quarter. Bank of Montreal Can now owns 36,573 shares of the company’s stock worth $2,223,000 after buying an additional 6,297 shares in the last quarter. Finally, Suntrust Banks Inc. increased its stake in Dentsply International by 56.4% in the fourth quarter. Suntrust Banks Inc. now owns 19,214 shares of the company’s stock worth $1,169,000 after buying an additional 6,930 shares in the last quarter.
DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.